spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Hologic 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 21 Jul 2026
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2026
Castle Biosciences' TissueCypher(R) Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus
Diagnostics Oncology Gastroenterology
 HSMN NewsFeed - 2 Jun 2026
Altesa BioSciences Appoints Brett Haumann, MBBCh, MBA, to its Board of Directors and Gwen Skloot, MD, ATSF, as Senior Vice President for Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2026
Boston Scientific receives FDA clearance for the Asurys(TM) Fluid Management System
Devices Surgery FDA
 HSMN NewsFeed - 19 Feb 2026
Altesa BioSciences Closes Oversubscribed $75 Million Series B Financing to Transform Treatment of Chronic Lung Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2026
Mammotome Launches First In-Room MR Vacuum-Assisted Breast Biopsy System
Devices Product Launch
 HSMN NewsFeed - 12 Nov 2025
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
Devices Neurology Venture Capital
 HSMN NewsFeed - 6 Aug 2025
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2025
Alpheus Medical Publishes Promising Early Clinical Results of Sonodynamic Therapy for the Treatment of Newly Diagnosed Glioblastomas
Devices Neurosurgery Oncology
 HSMN NewsFeed - 13 Feb 2025
Roche Elecsys sFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Raliable Way to Predict the Risk of Developing Severe Preeclampsia
Diagnostics FDA
 HSMN NewsFeed - 8 Jan 2025
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 15 Oct 2024
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
Devices Dermatology FDA
 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 May 2024
PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics
Diagnostics Oncology Personnel
 HSMN NewsFeed - 3 Apr 2024
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 Feb 2024
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
Diagnostics Oncology Personnel
 HSMN NewsFeed - 16 Jan 2024
Orlucent Demonstrates Accurate, Non-Invasive Detection in vivo of Melanoma-Related Activity Using First-in-Kind Handheld Mole Imaging System
Devices Dermatology
 HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2023
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2023
DCISionRT(R) by PreludeDx(TM) Receives Advanced Diagnostic Laboratory Test (ADLT) Status Approval from the Centers for Medicare & Medicaid Services
Diagnostics Oncology
 HSMN NewsFeed - 23 Dec 2022
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 22 Nov 2022
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
Devices Dermatology FDA
 HSMN NewsFeed - 15 Nov 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2022
Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 18 Oct 2022
Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2022
AbbVie terminates collaboration with BioArctic on alpha-synuclein portfolio
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2022
TPX-100: OrthoTrophix Presents New Data Suggesting Joint Bone Shape as a Possible Surrogate Marker for Virtual Joint Replacement in Knee Osteoarthritis
Biopharmaceuticals Regenerative Medicine Orthopaedics
 HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Mar 2022
Spine BioPharma Completes Series B Financing
Biopharmaceuticals Orthopaedic Venture Capital
 HSMN NewsFeed - 23 Mar 2022
TendoNova wins FDA Clearance for Its New Microinvasive Ocelot Surgical Tool
Devices Surgery FDA
 HSMN NewsFeed - 31 Jan 2022
Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany
Biopharmaceuticals
 HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution
 HSMN NewsFeed - 6 Jan 2022
BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists
Devices Dental FDA
 HSMN NewsFeed - 2 Dec 2021
UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2021
FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Oct 2021
GC Aesthetics(R) Achieves Compelling Surgical And Patient Care Results With FixNip NRI(TM), The Revolutionary Nipple Reconstruction Device
Devices Surgery
 HSMN NewsFeed - 9 Aug 2021
SKYRIZI(R) (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 30 Jun 2021
Minerva Surgical Issues Update on U.S. Supreme Court Ruling on Assignors Estoppel
Devices Litigation
 HSMN NewsFeed - 14 Jun 2021
KT and NeuroSigma Announce Strategic Digital Health Partnership
Devices
 HSMN NewsFeed - 12 May 2021
Centers for Medicare and Medicaid Services (CMS) Issues Permanent J-Code for Tolmar's FENSOLVI(R) Effective July 1, 2021
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 7 May 2021
LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema
Devices Ophthalmology
 HSMN NewsFeed - 6 May 2021
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 12 Apr 2021
Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Feb 2021
Therapeutic Solutions International Acquires Stem Cell Therapy That Successfully Completed FDA Double Blind Placebo Controlled Efficacy Study for Lung Disease
Regenerative Medicine Acquisitions
 HSMN NewsFeed - 16 Dec 2020
Neuron23(TM) Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Nov 2020
Echolight Announces New Executive Hires
Devices Personnel
 HSMN NewsFeed - 18 Nov 2020
NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 29 Oct 2020
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Oct 2020
BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy, Receives FDA Fast Track Designation for PKU Investigational Gene Therapy, BMN 307
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Sep 2020
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Aug 2020
MagVenture receives FDA clearance for OCD
Devices Neurology FDA
 HSMN NewsFeed - 30 Jul 2020
Jardiance(R) meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
Diagnostics Oncology FDA
 HSMN NewsFeed - 21 Jul 2020
Data from Lilly at Alzheimer's Association International Conference 2020(R) (AAIC 2020) to Showcase Clinical Advances in Alzheimer's Research
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 May 2020
New Oncotype DX(R) Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results
Diagnostics Oncology
 HSMN NewsFeed - 12 May 2020
Travecta Therapeutics Secures $15 Million in Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 4 May 2020
FDA Approves FENSOLVI(R) (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Mar 2020
Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium(R) (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Mar 2020
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2020
Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Feb 2020
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 12 Feb 2020
Avidity Biosciences Appoints Joseph Baroldi as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2020
Studies Support Use of the Accuray TomoTherapy(R) System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
Devices Oncology
 HSMN NewsFeed - 10 Dec 2019
Soliton Appoints Mary Stoll as Senior Director of Clinical Development
Devices Dermatology Personnel
 HSMN NewsFeed - 25 Nov 2019
Alkermes Completes Acquisition of Rodin Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Oct 2019
European Commission Approves Astellas' XOSPATA(TM) (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Sep 2019
Biohaven's Verdiperstat, An Oral Myeloperoxidase Inhibitor, Selected For Platform Trial Collaboration At Massachusetts General Hospital's Healey & AMG Center For Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Sep 2019
Kaia Health Announces $8 Million in Funding Led by Optum Ventures
Devices Venture Capital
 HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 5 Aug 2019
Vascular Graft Solutions Announces CE Mark Approval for FRAME FR External Support for AV Fistula Repair
Devices Regulatory
 HSMN NewsFeed - 31 Jul 2019
Biohaven Enrolls First Patient In Phase 3 Clinical Trial Of Verdiperstat, Oral Myeloperoxidase Inhibitor, For The Treatment Of Multiple System Atrophy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Jul 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Jun 2019
European Radiology Profiles Seno Medical's Ground-Breaking Breast Cancer Diagnostic Technology
Devices Radiology
 HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2019
Candela(R) Announces Results of The Largest Published Study of Infants And Children Using Vbeam(R) Laser System
Devices Dermatology
 HSMN NewsFeed - 1 Mar 2019
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI(TM)) for the Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 20 Feb 2019
ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy
Regenerative Medicine
 HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 12 Dec 2018
Lilly and AC Immune Announce License and Collaboration Agreement
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 9 Nov 2018
Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Nov 2018
BioArctic's Partner AbbVie Exercises its Option to License the Alpha-synuclein Antibody Portfolio for Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 23 Oct 2018
COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Oct 2018
Agendia Announces Level 1 Inclusion of MammaPrint(R) Breast Cancer Test in Updated National Comprehensive Cancer Network(R) (NCCN) Guidelines
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 8 Oct 2018
Bausch Health's BRYHALI(TM) (halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 21 Sep 2018
CHMP Recommends Approval of Buvidal(R) (CAM2038) for the Treatment of Opioid Dependence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Diagnostics Personalized Medicine Oncology Product Launch
 HSMN NewsFeed - 13 Sep 2018
Olympus Introduces EZ Shot 3 Plus 25 G EUS Needle with Enhanced Maneuverability for Uncompromised Access to Any Lesion, Consistent Performance to Potentially Reduce Procedural Costs and Procedure Time
Devices Oncology FDA Product Launch
 HSMN NewsFeed - 13 Sep 2018
AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 16 Aug 2018
Hologic Launches Fluent(TM) Fluid Management System for Hysteroscopic Procedures
Devices Surgery Product Launch
 HSMN NewsFeed - 24 Jul 2018
GenomeDx Announces Medicare Draft Local Coverage Determination (LCD) for Decipher Prostate Biopsy Genomic Classifier
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 11 Jul 2018
Hologic's Cynosure Division Launches TempSure(TM) Vitalia In North America
Devices Product Launch
 HSMN NewsFeed - 25 Jun 2018
Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*
Diagnostics FDA
 HSMN NewsFeed - 22 Jun 2018
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jun 2018
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Devices Interventional Radiology Orthopaedic FDA
 HSMN NewsFeed - 29 May 2018
TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten(R) for the Treatment of Intradialytic Hypotension
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 May 2018
Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 1 May 2018
Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Diagnostics Personalized Medicine Oncology Reimbursement
 HSMN NewsFeed - 25 Apr 2018
FDA Approval of ThinPrep(R) Integrated Imager Expands Automated Imaging for Pap Testing to More Labs
Devices Diagnostics Oncology FDA
 HSMN NewsFeed - 20 Apr 2018
Women Treated with Hologic's NovaSure(R) Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva
Devices Interventional
 HSMN NewsFeed - 18 Apr 2018
Tetherex Pharmaceuticals, Inc. Completes $50M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 27 Mar 2018
FDA Approves New Innovations on Hologic's 3Dimensions(TM) Mammography System, the Fastest, Highest Resolution Breast Tomosynthesis System Ever(1)
Devices Oncology Radiology FDA
 HSMN NewsFeed - 2 Mar 2018
Philips and Hologic announce global partnership agreement to provide integrated imaging solutions for women's health
Devices Radiology
 HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Feb 2018
Mark Casey Joins Mallinckrodt as General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2018
Bracco Diagnostics Inc. receives U.S. Food and Drug Administration (FDA) approval for use of MultiHance(R) (gadobenate dimeglumine) injection in magnetic resonance imaging of the central nervous system in pediatric patients younger than two years of age
Biopharmaceuticals Devices Diagnostics Radiology FDA
 HSMN NewsFeed - 30 Jan 2018
BridgeBio Pharma Licenses Late-Stage Oncology Drug Infigratinib to Tackle FGFR-Driven Maladies; Establishes New Subsidiary QED Therapeutics with $65 Million in Initial Financing
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Jan 2018
Aptima(R) HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
Diagnostics FDA
 HSMN NewsFeed - 22 Jan 2018
Hologic's Cynosure Division Launches TempSure(TM) Envi
Devices Dermatology Product Launch
 HSMN NewsFeed - 18 Jan 2018
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 17 Jan 2018
Relmada Therapeutics Acquires Global Rights to Develop and Market Dextromethadone for Treatment of Disorders of the Nervous System
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 9 Jan 2018
Xcision Receives FDA 510(k) Clearance for the GammaPod Stereotactic Radiotherapy System for Breast Cancer
Devices Oncology FDA
 HSMN NewsFeed - 5 Jan 2018
FDA Approves XGEVA(R) (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Dec 2017
Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi(TM) (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Diagnostics FDA Product Launch
 HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 30 Nov 2017
Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 24 Nov 2017
Hologic Receives FDA 510(k) Clearance of Quantra(TM) 2.2 Breast Density Assessment Software
Devices Radiology Oncology FDA
 HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 1 Nov 2017
Hologic Launches the MyoSure(R) MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office
Devices Product Launch
 HSMN NewsFeed - 27 Sep 2017
Hologic Receives FDA 510(k) Clearance to Market SculpSure(R) for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin)
Devices Dermatology FDA Product Launch
 HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Sep 2017
Janssen Receives CHMP Positive Opinion for Guselkumab Recommending Approval for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 Sep 2017
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2017
Mavenclad (Cladribine Tablets) Demonstrates Sustained Disease Control over 4 Years with Maximum of Only 20 Days Oral Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Aug 2017
Hologic Announces Availability of New Brevera(R) Breast Biopsy System with CorLumina(R) Imaging Technology
Devices Oncology Product Launch
 HSMN NewsFeed - 25 Aug 2017
European Commission Grants Approval for Mavenclad (Cladribine Tablets)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 8 Aug 2017
AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device
Devices Cardiology FDA
 HSMN NewsFeed - 5 Jul 2017
Recordati Rare Diseases Introduces New PANHEMATIN(R) (Hemin for Injection) Dosage Strength for Treatment of Acute Intermittent Porphyria (AIP)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 30 Jun 2017
Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jun 2017
Hologic's New Panther Fusion(R) System, Flu and Respiratory Assays Now CE Marked in Europe
Diagnostics Regulatory
 HSMN NewsFeed - 29 Jun 2017
HYCOR Biomedical Announces Senior Level Appointments to Management Team
Diagnostics Personnel
 HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 20 Jun 2017
NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
Devices Oncology Radiology
 HSMN NewsFeed - 20 Jun 2017
Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 & 2
Diagnostics FDA
 HSMN NewsFeed - 19 Jun 2017
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA(R) (denosumab) To Include Multiple Myeloma Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Jun 2017
Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure(R) for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs
Devices FDA
 HSMN NewsFeed - 13 Jun 2017
TECHLAB(R) Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK(TM) To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite
Diagnostics FDA
 HSMN NewsFeed - 7 Jun 2017
FDA Approves Hologic's Genius(TM) 3D Mammography(TM) Exam as the Only Mammogram Superior for Women with Dense Breasts*
Devices Radiology Oncology FDA
 HSMN NewsFeed - 22 May 2017
Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY(TM) (Romosozumab) In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2017
Biotheranostics Appoints Don Hardison as New CEO
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 2 May 2017
Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Results from Long-term Phase 3 Safety Study of CAM2038
Biopharmaceuticals
 HSMN NewsFeed - 26 Apr 2017
Urology of Virginia First US Practice to Acquire Novel ExactVu(TM) Micro-Ultrasound System for Prostate Imaging and Biopsy
Devices Urology Oncology
 HSMN NewsFeed - 17 Apr 2017
New ASTRO Guideline Establishes Standard of Care for Curative Treatment of Oropharyngeal Cancer with Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch
 HSMN NewsFeed - 16 Feb 2017
FDA Grants PMA Approval for Hologic's Aptima(R) Hepatitis C Quant Dx Assay
Diagnostics FDA
 HSMN NewsFeed - 14 Feb 2017
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
Biopharmaceuticals Mergers & Acquisitions Venture Capital
 HSMN NewsFeed - 1 Feb 2017
Bovie Medical Provides J-Plasma(R) Update
Devices Surgery Distribution
 HSMN NewsFeed - 23 Jan 2017
Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Jan 2017
Getinge Group Announces U.S. Launch of Total Lift Bed(TM) for ICU Patients
Devices Product Launch
 HSMN NewsFeed - 10 Jan 2017
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS(R) system
Devices Product Launch
 HSMN NewsFeed - 5 Jan 2017
Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
Devices Personnel
 HSMN NewsFeed - 4 Jan 2017
Titan Pharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Jan 2017
Dermira Initiates Phase 3 Clinical Program in Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 23 Dec 2016
Progenics Pharmaceuticals Announces Independent Committee’s Positive Recommendation for Continuation of Phase 3 Clinical Trial of SPECT/CT Imaging Agent 1404
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Nov 2016
miRagen Therapeutics and Signal Genetics Sign Merger Agreement
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2016
European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Oct 2016
FDA Grants Priority Review to Genentech’s Lucentis(R) (Ranibizumab Injection) Supplemental Biologics License Application for Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Aug 2016
Avelas Biosciences Completes $20 Million Series C Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 1 Aug 2016
Mylan Launches Generic Dexedrine(R) Capsules
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 22 Jul 2016
Amgen and UCB Submit Biologics License Application for Romosozumab to the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jul 2016
Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma(R)
Devices Surgery Distribution
 HSMN NewsFeed - 14 Jun 2016
Rivanna Medical Prepares for European Market Adoption of Accuro(TM) with the Appointment of New Vice President of Sales (EMEA)
Devices Personnel
 HSMN NewsFeed - 10 Jun 2016
Merck to Acquire Afferent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jun 2016
Sanifit Appoints Preston S. Klassen MD, MHS as Chief Medical Officer and Announces new US Subsidiary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2016
BioVentrix receives FDA IDE Approval for its Pivotal Clinical Trial, ALIVE
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 May 2016
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Diagnostics Devices Oncology
 HSMN NewsFeed - 16 May 2016
The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2016
Hologic Introduces the MyoSure(R) REACH Device to Help Physicians Access the Hard-to-Reach Upper Third of the Uterine Cavity
Devices Product Launch
 HSMN NewsFeed - 21 Apr 2016
Hologic Announces FDA Clearance and Commercial Availability of the Affirm(TM) Prone Biopsy System, the First 2D/3D(TM) Imaging-Guided Dedicated Prone Biopsy System
Devices Oncology Radiology FDA Product Launch
 HSMN NewsFeed - 6 Apr 2016
Sorrento Appoints Kevin M. Herde As Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2016
Pivotal Phase III Trial of enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2016
LEO Pharma Receives Scientific Approval of Enstilar(R) for the Treatment of Psoriasis in EU
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 10 Mar 2016
ProMark(R) Prostate Cancer Prognostic Now Included in NCCN Guidelines
Diagnostics Oncology
 HSMN NewsFeed - 26 Feb 2016
Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Feb 2016
Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 1 Feb 2016
Seno Medical Instruments Appoints Tom Umbel as Chief Executive Officer
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 18 Nov 2015
Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Nov 2015
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Nov 2015
Eiger BioPharmaceuticals Announces License Agreement with Nippon Kayaku to Develop Bestatin(TM) (ubenimex) for Inflammatory Diseases Involving LTB4
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Nov 2015
Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as Treatment for Patients with Mild Alzheimer's Disease
Devices Neurology
 HSMN NewsFeed - 4 Nov 2015
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
Devices Acquisitions
 HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Oct 2015
Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Oct 2015
IlluminOss Medical Appoints Manny Avila as Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 9 Oct 2015
Biogen Announces Departure of Tony Kingsley
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Aug 2015
Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director
Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Aug 2015
FDA Approves the First 3D Printed Drug Product
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 21 Jul 2015
Ophthotech Announces New Senior Leadership Appointments
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 6 Apr 2015
VytronUS, Inc. Attracts Industry Veteran John Pavlidis as New President and Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 3 Mar 2015
Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors
Devices Personnel
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 13 Nov 2014
Monteris Medical Announces $30 Million Equity Financing
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 4 Nov 2014
Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Scar Management Hydrogel
Devices Wound Care Dermatology Regulatory
 HSMN NewsFeed - 6 Oct 2014
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 10 Sep 2014
Avelas Biosciences Extends Series B Financing to $7.4 Million to Support Clinical Development of Real-Time Cancer Visualization Technology
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 6 Aug 2014
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
Devices Drug Delivery Endocrinology Product Launch
 HSMN NewsFeed - 5 Aug 2014
Caris Molecular Intelligence(TM) Identifies Key Biomarkers of Clinical Benefit and Resistance to Chemotherapy through Multi-Technology Tumor Profiling
Diagnostics Oncology
 HSMN NewsFeed - 30 Jun 2014
CHMP Recommends EU Approval of VIZAMYL(TM) (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque
Biopharmaceuticals Radiology Neurology Regulatory
 HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jun 2014
Benvenue Medical Secures $64 Million Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 11 Jun 2014
Navidea Biopharmaceuticals’ Lymphoseek(R) (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation in Tumor-Positive Sentinel Lymph Nodes in Post-Hoc Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jun 2014
Auxogyn Receives FDA Clearance for Its Eeva(TM) System
Devices FDA
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Apr 2014
Bristol-Myers Squibb Acquires iPierian, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2014
Steve Gex Named CEO at Focal Therapeutics
Devices Personnel
 HSMN NewsFeed - 17 Apr 2014
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
Devices Personnel
 HSMN NewsFeed - 15 Apr 2014
AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 3 Apr 2014
Eko Devices Launches Eko, a Groundbreaking Stethoscope Technology and Software Designed to Enhance Cardiac Care
Devices Cardiology Product Launch
 HSMN NewsFeed - 3 Apr 2014
Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Mar 2014
NeuroPhage, Inc. Raises $17 Million In Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Mar 2014
Exelixis Receives Approval for COMETRIQ(R) (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 28 Feb 2014
InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2014
BioLineRx Appoints Dr. Sandra Panem to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Feb 2014
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 Jan 2014
Janssen Announces New Group Targeting Unmet Global Health Needs
Biopharmaceuticals
 HSMN NewsFeed - 22 Jan 2014
LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 15 Jan 2014
AbbVie Announces Initiation of Pivotal Phase 3 Study of Veliparib (ABT-888) for Patients with Early-Stage Triple-Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jan 2014
LabCorp to Offer New FDA approved Breast Cancer Prognostic Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 7 Jan 2014
DySIS Medical Appoints Robert Cascella as Chairman
Devices Personnel
 HSMN NewsFeed - 10 Dec 2013
FDA Grants Fast Track Designation to Navidea Biopharmaceuticals’ Lymphoseek(R) for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 9 Dec 2013
Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
Devices Diagnostics Personnel
 HSMN NewsFeed - 6 Dec 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(R) for the Treatment of Peyronie's Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2013
First U.S. Implants of New Medtronic Deep Brain Stimulation System Advance Ground-Breaking Research Into Brain Activity While Therapy Is Delivered
Devices Neurology Personalized Medicine
 HSMN NewsFeed - 4 Dec 2013
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
Diagnostics Urology Oncology
 HSMN NewsFeed - 17 Oct 2013
Health Canada Approves A New Treatment Option For Patients With Gastrointestinal Stromal Tumours (GIST), A Rare Form Of Sarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Oct 2013
Myriad's myPath(TM) Melanoma Test is Highly Effective in Verification Study
Diagnostics Oncology Dermatology
 HSMN NewsFeed - 4 Oct 2013
MetaStat's MetaSite Breast(TM) Diagnostic Assay Predicts Metastasis in Breast Cancer Study
Diagnostics Oncology
 HSMN NewsFeed - 2 Oct 2013
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
Devices Dermatology Regulatory
 HSMN NewsFeed - 26 Sep 2013
Neurotrack Raises $2 Million Series A Led by Founders Fund
Diagnostics Neurology Venture Capital
 HSMN NewsFeed - 10 Sep 2013
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
Diagnostics Oncology
 HSMN NewsFeed - 3 Sep 2013
Subanalysis of Phase III ARISTOTLE Trial of Eliquis(R) (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2013
UK's NICE Final Appraisal Determination (FAD) Confirms Positive Recommendation for ThromboGenics' JETREA(R) for Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory Reimbursement
 HSMN NewsFeed - 30 Aug 2013
Bayer's Stivarga(R) (regorafenib) Tablets Approved in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Aug 2013
FDA Accepts Boehringer Ingelheim's Supplemental New Drug Application for Use of Dabigatran Etexilate Mesylate in Deep Vein Thrombosis and Pulmonary Embolism
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Aug 2013
Hologic Launches New Bone Densitometer Platform for Osteoporosis, Cardiovascular Disease, and Obesity Assessment
Devices Radiology Product Launch
 HSMN NewsFeed - 7 Aug 2013
New Medtronic Deep Brain Stimulation System the First to Sense and Record Brain Activity While Delivering Therapy
Devices Neurology
 HSMN NewsFeed - 2 Aug 2013
Germany's IQWiG Confirms That ThromboGenics' JETREA(R) Demonstrates Major Added Value for the Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 31 Jul 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jul 2013
Given Imaging's PillCam(R) COLON Cleared in Japan, World's Second Largest Healthcare Market
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 5 Jul 2013
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jul 2013
FDA Grants Genentech’s Perjeta Regimen Priority Review for Use Before Surgery in HER2-Positive Early Stage Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Jun 2013
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jun 2013
ThromboGenics' JETREA(R) Receives Positive Initial NICE Recommendation for Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 5 Jun 2013
Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 24 May 2013
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 May 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2013
New Study Shows Effect of Neupro(R) (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 May 2013
ASTRO and AUA Issue Joint Guideline for Radiation Therapy After Prostatectomy
Devices Urology Oncology
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Mar 2013
Clearside Biomedical, Inc. Names Stephen H. Lang Vice President, Commercial Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 25 Feb 2013
Clearside Biomedical, Inc. Names Rafael V. Andino Vice President, Product Development
Biopharmaceuticals Ophthalmology Drug Delivery Personnel
 HSMN NewsFeed - 14 Feb 2013
Study Results of Dune Medical's Breast Biopsy System Presented at the Annual Meeting of the Israel Society of Breast Imaging
Devices Diagnostics Oncology
 HSMN NewsFeed - 6 Feb 2013
Guided Therapeutics to Develop Esophageal Cancer Product; Acquires Intellectual Property Rights from Konica Minolta
Devices Oncology Acquisitions
 HSMN NewsFeed - 22 Jan 2013
Hologic Announces Organizational Changes to its Diagnostics Segment; Integration of Gen-Probe Proceeding Ahead of Schedule
Diagnostics Personnel
 HSMN NewsFeed - 22 Jan 2013
Physicians Report Successful Clinical Use of the DFINE STAR(TM) Tumor Ablation System in Malignant Lesions of the Spine
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 18 Jan 2013
ThromboGenics Receives Positive CHMP Opinion for JETREA(R)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 14 Jan 2013
Hologic Announces FDA Clearance of APTIMA Trichomonas for Use on PANTHER System
Diagnostics FDA
 HSMN NewsFeed - 9 Jan 2013
The Oslo Breast Cancer Screening Trial Concludes that the Use of 3D Mammography in Combination with a 2D Breast Exam Finds Significantly More Cancers than a 2D Breast Exam Alone
Devices Oncology Radiology
 HSMN NewsFeed - 3 Jan 2013
Sensimed AG Receives a New Reimbursement Code in the USA by the AMA for Intraocular Pressure Monitoring
Devices Reimbursement Ophthalmology
 HSMN NewsFeed - 28 Dec 2012
K-V Pharmaceutical Receives Court Approval of Hologic Settlement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology
 HSMN NewsFeed - 20 Dec 2012
Covidien Announces Five-Year Results from the ClosureFast(TM) Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease
Devices Interventional
 HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Nov 2012
URGENT NOTICE -- DRUG RECALL: Boehringer Ingelheim Pharmaceuticals, Inc. Initiates a Voluntary Recall of a Single Manufacturing Lot of Pradaxa(R) (dabigatran etexilate mesylate) Capsules 75mg in the U.S. and Puerto Rico
Biopharmaceuticals Cardiology Product Recall
 HSMN NewsFeed - 23 Oct 2012
BSD Medical Reports Clinical Study Demonstrates Threefold Increase in Tumor Destruction from the Addition of Hyperthermia for Advanced Rectal Cancer Patients
Devices Oncology
 HSMN NewsFeed - 18 Oct 2012
VuCOMP’s M-Vu(R) Computer-Aided Detection (CAD) System Receives FDA Approval for Digital Mammography
Devices Radiology FDA
 HSMN NewsFeed - 16 Oct 2012
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
Diagnostics Oncology FDA
 HSMN NewsFeed - 25 Sep 2012
Gynecor, a Division of Bostwick Laboratories, Inc., Adds New State-of-the-Art Lab Technology to Help Physicians Identify Patients at Risk for Cervical Cancer, Improve Treatment Decisions
Diagnostics Oncology
 HSMN NewsFeed - 20 Sep 2012
Innovative Ultrasound Company SuperSonic Imagine Receives FDA Clearance to Enhance ShearWave(TM) Elastography Imaging with a Real-Time Adjustable Numerical Scale (ANS)
Devices FDA
 HSMN NewsFeed - 30 Aug 2012
Aerpio Therapeutics Completes $27 Million Series A Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 1 Aug 2012
Hologic Completes Acquisition Of Gen-Probe
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 1 Aug 2012
Elekta appoints Ian Alexander Executive Vice President Region Europe, Africa, Latin America and Middle East
Devices Oncology Personnel
 HSMN NewsFeed - 17 Jul 2012
Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologic's Acquisition of Gen-Probe
Devices Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2012
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 2 Jul 2012
BG Medicine, Inc. Appoints Bill Densel, General Manager, CardioSCORE
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 19 Jun 2012
InTouch Health Announces New FDA 510(k) Clearance for Its Remote Presence Acute Care Telemedicine Devices
Devices Monitoring FDA
 HSMN NewsFeed - 1 Jun 2012
Cardinal Health to Manufacture, Distribute Eli Lilly and Company's Brain Imaging Agent Amyvid(TM) (Florbetapir F 18 Injection)
Biopharmaceuticals Radiology Neurology
 HSMN NewsFeed - 1 Jun 2012
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 21 May 2012
AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer
Devices Personnel
 HSMN NewsFeed - 7 May 2012
KYTHERA Biopharmaceuticals Announces Presentation of Positive Results from First of Two ATX-101 European Phase III Trials for Reduction of Submental Fat
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 May 2012
Brachytherapy as Effective for Local Breast Cancer Control as Whole Breast Irradiation According to New Study
Devices Oncology
 HSMN NewsFeed - 30 Apr 2012
Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic
Devices Litigation
 HSMN NewsFeed - 30 Apr 2012
Hologic to Acquire Gen-Probe
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2012
Oligomerix, Inc. Completes $2 Million Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 9 Apr 2012
DA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
Biopharmaceuticals Radiology Neurology FDA
 HSMN NewsFeed - 3 Apr 2012
Neupro(R) Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Mar 2012
Merz Pharmaceuticals Introduces New Mederma(R) Advanced Scar Gel
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 19 Mar 2012
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 15 Mar 2012
Simpirica Spine Receives Approval to Begin U.S. IDE Pivotal Study of Its LimiFlex(TM) Spinal Stabilization System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 14 Mar 2012
DFINE Announces First U.S. Patient Treated with the STAR Ablation System
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 29 Feb 2012
Conceptus(R) Receives FDA Approval for Compatible Use of Hologic's NovaSure(R) with Essure(R) Inserts in Place
Devices
 HSMN NewsFeed - 23 Feb 2012
MelaFind(R) Results Improve Detection of Melanoma, Study Shows
Devices Dermatology Oncology
 HSMN NewsFeed - 20 Feb 2012
FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis
Diagnostics Oncology FDA
 HSMN NewsFeed - 16 Feb 2012
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
Diagnostics Personnel
 HSMN NewsFeed - 13 Feb 2012
Valeant Pharmaceuticals to Acquire Eyetech
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2011
Guided Therapeutics Selects Eurosurgical Ltd to Distribute LuViva(TM) Advanced Cervical Scan in the United Kingdom
Devices Oncology Distribution
 HSMN NewsFeed - 6 Dec 2011
Atossa Genetics Launches ForeCYTE Breast Health Test(SM) for Breast Cancer Risk Assessment
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 18 Nov 2011
Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2011
Merck Launches NEXPLANON(R) (etonogestrel implant) 68 mg in the United States – A Long-Acting Reversible Hormonal Contraceptive Effective For Up to Three Years
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
Devices Oncology Distribution
 HSMN NewsFeed - 18 Oct 2011
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2011
Biogen Idec Promotes Tony Kingsley to Run Global Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2011
Boehringer Ingelheim to Launch RE-ALIGN Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Aug 2011
Restoration Robotics Receives $41 Million in Series C Financing
Devices Dermatology Venture Capital
 HSMN NewsFeed - 25 Jul 2011
St. Gallen International Breast Cancer Expert Panel Guidelines Include Oncotype DX(R) as Predictor of Chemotherapy Benefit
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Jun 2011
Tenex Health Announces $5 Million in Series A Financing to Commercialize the TX1(TM) System
Devices Surgery Venture Capital
 HSMN NewsFeed - 26 May 2011
Genetic Technologies Files New Patent Infringement Suit in USA
Biopharmaceuticals Diagnostics Oncology Litigation
 HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 May 2011
FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear Palsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Apr 2011
Dune Medical's MarginProbe Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re-excision in Landmark Lumpectomy Surgery Trial
Devices Oncology
 HSMN NewsFeed - 14 Apr 2011
ARTAS System Receives FDA Clearance for Ground-Breaking Technology Treating Hair Loss
Devices FDA
 HSMN NewsFeed - 8 Apr 2011
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 Apr 2011
Alexion Submits Applications for Soliris(R) (Eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the United States and European Union
Biopharmaceuticals
 HSMN NewsFeed - 6 Apr 2011
Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids
Devices Litigation
 HSMN NewsFeed - 16 Mar 2011
MAQUET Cardiovascular Receives European CE Mark for FUSION BIOLINE Vascular Graft
Devices Regulatory
 HSMN NewsFeed - 9 Mar 2011
Tenex Health Receives FDA Clearance for Innovative TX1(TM) Tissue Removal System
Devices FDA
 HSMN NewsFeed - 9 Mar 2011
Pro-Pharmaceuticals Names Peter G. Traber, M.D., Former GlaxoSmithKline Chief Medical Officer & President Emeritus of Baylor College of Medicine, President & Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2011
Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's Disease
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2011
Guided Therapeutics Provides Update on FDA PMA Review of Cervical Cancer Test
Devices Diagnostics Oncology FDA
 HSMN NewsFeed - 2 Mar 2011
Naviscan Announces European Launch of Positron Emission Mammography
Devices Radiology Oncology
 HSMN NewsFeed - 28 Feb 2011
FDA Approves INTUNIV(R) (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Devices Radiology FDA
 HSMN NewsFeed - 8 Feb 2011
Hologic Targets Women's Health Professionals at ECR 2011
Devices Radiology Oncology
 HSMN NewsFeed - 7 Feb 2011
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 4 Feb 2011
FDA Approves Makena, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jan 2011
Baxter Introduces OLIMEL in Canada as the First Triple-Chamber Bag for Nutrition
Devices
 HSMN NewsFeed - 26 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2010
Pico-Tesla Starts Pilot Study of Magneceutical(R) Therapy For Fibromyalgia
Devices
 HSMN NewsFeed - 13 Dec 2010
Lilly Suspends Phase III Trial in Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2010
Pertuzumab and Herceptin Plus Chemotherapy Significantly Improved the Rate of Complete Tumor Disappearance in Study of Women With Newly Diagnosed, Early-Stage HER2-Positive Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2010
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Dec 2010
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
Devices Diagnostics Oncology FDA
 HSMN NewsFeed - 23 Nov 2010
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Devices Radiology Oncology FDA
 HSMN NewsFeed - 4 Nov 2010
Study Shows BSGI/MBI is More Accurate in Establishing Tumor Size After Neoadjuvant Chemotherapy in Patients With Breast Cancer Than Other Imaging Modalities
Devices Radiology Oncology
 HSMN NewsFeed - 31 Oct 2010
CyberKnife Radiosurgery for Early-Stage Breast Cancer
Devices Oncology
 HSMN NewsFeed - 26 Oct 2010
aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
Biopharmaceuticals Venture Captial
 HSMN NewsFeed - 20 Oct 2010
FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Neurology FDA
 HSMN NewsFeed - 6 Oct 2010
New Data Demonstrate Treatment With STELARA(R) (Black Triangle Drug) (ustekinumab) Results in Sustained Improvements in Psoriasis Severity and Quality of Life up to Three Years
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 27 Sep 2010
Guided Therapeutics Files Premarket Approval Application for Non-Invasive Cervical Cancer Scanner with FDA
Devices Diagnostics Oncology FDA
 HSMN NewsFeed - 25 Sep 2010
Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
Devices Radiology Oncology FDA
 HSMN NewsFeed - 24 Sep 2010
ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 14 Sep 2010
Vicor Technologies Names Christopher Vissman National Sales Manager
Devices Diagnostics Personnel
 HSMN NewsFeed - 30 Aug 2010
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Aug 2010
TomTec introduces 4D MV-Assessment, the new 3D solution for improved diagnostic confidence in Mitral Valve therapy at the ESC (European Society of Cardiology) congress in Stockholm
Devices Cardiology
 HSMN NewsFeed - 10 Aug 2010
Avid Radiopharmaceuticals Expands R&D Capabilities with Appointment of Dr. Mark A. Mintun as Chief Medical Officer
Biopharmaceuticals Radiology Neurology Personnel
 HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 28 Jul 2010
Study Showed the Clinically Significant Therapeutic Benefit of Neupro(R) (rotigotine transdermal system) in the Treatment of Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 27 Jul 2010
Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 12 Jul 2010
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
Diagnostics Oncology
 HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jun 2010
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device
Devices Oncology Licensing
 HSMN NewsFeed - 22 Jun 2010
QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne(R)) Combination Therapy in Exudative AMD
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Jun 2010
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2010
Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Jun 2010
Cytheris Closes 12 Million ($15 Million) Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jun 2010
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 May 2010
Hologic Unveils Next Generation NovaSure Endometrial Ablation System
Devices
 HSMN NewsFeed - 11 May 2010
BrainStorm Announces Significant Milestones Achieved and 2009 Review
Regenerative Medicine Neurology
 HSMN NewsFeed - 28 Apr 2010
Lycera Achieves $11 Million Second Tranche in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Apr 2010
Mirina Corporation Closes Series A-1 Financing Led by Versant Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Apr 2010
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro(R) (Rotigotine)
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 14 Apr 2010
Hybridyne Imaging Technologies Receives FDA Clearance for New Medical Imaging System
Devices Oncology FDA
 HSMN NewsFeed - 13 Apr 2010
New Data Show Sustained 5-Year Benefit of Neupro(R) (Rotigotine Transdermal System) for Symptoms of Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 19 Feb 2010
Hologic Announces Settlement In Patent Infringement Suits
Devices Surgery Litigation
 HSMN NewsFeed - 19 Feb 2010
Ethicon Endo-Surgery Announces Agreement with Hologic Inc. To Resolve Patent Disputes
Devices Surgery Litigation
 HSMN NewsFeed - 16 Feb 2010
EntreMed Receives Orphan Drug Designation for ENMD-2076 in Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Feb 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jan 2010
Study Published in the American Journal of Ophthalmology Examines Investigational Use of Macugen in Patients With Branch Retinal Vein Occlusion (BRVO)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Jan 2010
Neomend Completes $30M Funding with Clarus Ventures, Other Investors
Devices Surgery Venture Capital
 HSMN NewsFeed - 21 Jan 2010
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 21 Jan 2010
Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Jan 2010
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals
 HSMN NewsFeed - 9 Dec 2009
6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Nov 2009
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology
 HSMN NewsFeed - 30 Nov 2009
Medipattern and Sentinelle Medical Inc. Announce Breast MRI Development Partnership
Devices Radiology Distribution
 HSMN NewsFeed - 26 Oct 2009
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Oct 2009
QLT restructures Visudyne(R) agreement
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 Oct 2009
National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
Devices Neurology
 HSMN NewsFeed - 7 Oct 2009
Carl Zeiss Speeds Brain Mapping and 3-D Reconstruction with Advanced Electron Microscopy and Analysis Instruments
Devices Neurology
 HSMN NewsFeed - 29 Sep 2009
Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Diagnostics Regulatory
 HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Janssen-Cilag's STELARA(R) (Black Triangle Drug) (ustekinumab) Approved by NICE for the Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 22 Sep 2009
Data Show Long-Term Mechanical Integrity of MitraClip(R) and Complete Healing Following Implantation of the Device for Mitral Valve Repair
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2009
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Sep 2009
FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer
Devices Oncology FDA
 HSMN NewsFeed - 30 Aug 2009
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 25 Aug 2009
Zargis Cardioscan(TM) Unveiled Through Global Marketing and Distribution Alliance With 3M Company
Devices Cardiology Distribution
 HSMN NewsFeed - 11 Aug 2009
Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain
Biopharmaceuticals Drug Delivery Surgery
 HSMN NewsFeed - 27 Jul 2009
John P. McDonough Joins Interlace Medical's Board of Directors
Devices Personnel
 HSMN NewsFeed - 10 Jul 2009
Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 1 Jul 2009
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 24 Jun 2009
Study Shows Medtronic Microdebrider Turbinoplasty is a Significantly More Effective, Long-Term Treatment Than Coblation(R) Radiofrequency for Nasal Obstructions(1)
Devices Surgery
 HSMN NewsFeed - 15 Jun 2009
QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Jun 2009
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly Improved Early Morning akinesia and was Generally Well Tolerated Over Four Years
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Jun 2009
Study Confirms Given Imaging's Bravo(R) pH Monitoring System to Be a Very Effective Diagnostic Tool for Assessing GERD
Devices Monitoring Gastroenterology
 HSMN NewsFeed - 1 Jun 2009
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 1 Jun 2009
BioLineRx Announces Positive Preliminary Results From the Phase I/II Trial of BL-1040, the First Injectable Device Addressing Pathological Cardiac Remodeling
Devices Interventional Cardiology
 HSMN NewsFeed - 29 May 2009
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 15 May 2009
AGI Therapeutics: Top-line results of Phase III study of Rezular
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 13 May 2009
UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2009
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Biopharmaceuticals Diagnostics Monitoring Endocrinology
 HSMN NewsFeed - 7 May 2009
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 5 May 2009
Clarient Launches New Breast Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 5 May 2009
Basilea's Toctino(R) receives marketing authorization in Spain
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 4 May 2009
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals
 HSMN NewsFeed - 20 Apr 2009
Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth
Devices
 HSMN NewsFeed - 9 Apr 2009
Encouraging Results Published on Use of TomoTherapy in Lung Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 7 Apr 2009
Cianna Medical Completes Funding Round for SAVI Technology
Devices Oncology Venture Capital
 HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 31 Mar 2009
Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2009
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Mar 2009
FDA Approves Two Hologic HPV Tests
Diagnostics FDA
 HSMN NewsFeed - 12 Mar 2009
Dune Medical Devices Appoints William Densel President U.S. and Chief Business Officer
Devices Oncology Surgery Personnel
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 24 Feb 2009
Imalux(R) Corporation and Preventive Oncology International(R), Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System
Devices Diagnostics Oncology
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Feb 2009
Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 19 Feb 2009
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation (DBS) Therapy for a Psychiatric Indication in the United States
Devices Neurology
 HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Regenerative Medicine Cardiology
 HSMN NewsFeed - 10 Feb 2009
Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial
Devices Diagnostics Oncology
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Diagnostics Acquisitions
 HSMN NewsFeed - 23 Jan 2009
Merck Serono's Oral Investigational Treatment Cladribine Tablets for Multiple Sclerosis Significantly Reduced Relapse Rate in Two-Year Phase III Pivotal Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jan 2009
Hydra Biosciences Raises $22 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jan 2009
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Jan 2009
Vicor Technologies Announces Receipt of 510(k) Approval to Market Its PD2i Analyzer
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 22 Dec 2008
Vicor Technologies Announces Appointment of Chief Accounting Officer
Devices Monitoring Cardiology Personnel
 HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 11 Dec 2008
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Nov 2008
Siemens Introduces New Standard of Care for Breast Ultrasound
Devices Radiology Oncology
 HSMN NewsFeed - 21 Nov 2008
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Nov 2008
Naviscan Receives 510(k) Clearance for Stereo Navigator(TM) - the First Commercially Available Breast PET-Guided Biopsy Feature
Devices Radiology Oncology FDA
 HSMN NewsFeed - 6 Nov 2008
Newly Published Data from Long-Term Study Show Neurostimulation Provides Sustained Leg Pain Relief, Improved Quality of Life and Functional Capacity
Devices Neurosurgery
 HSMN NewsFeed - 28 Oct 2008
ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
Devices Wound Care
 HSMN NewsFeed - 27 Oct 2008
One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 27 Oct 2008
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2008
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Biopharmaceuticals
 HSMN NewsFeed - 6 Oct 2008
CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 30 Sep 2008
OrthoLogic Corp. Announces New Company Name: Capstone Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 22 Sep 2008
Lifeline Biotechnologies, Inc. Forms First Warning Systems(TM), Inc.
Devices Diagnostics Oncology
 HSMN NewsFeed - 16 Sep 2008
Intact Medical Corporation's Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA
Devices FDA
 HSMN NewsFeed - 28 Aug 2008
New Treatment Launched to Help Improve Symptoms in People Suffering From Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 26 Aug 2008
New Publication Shows Cleviprex(TM) is Safe and Effective for Treatment of Acute, Severe Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 26 Aug 2008
DiagnoCure receives approval from the U.S. regulatory authorities and launches its Previstage(TM) GCC Colorectal Cancer Staging Test
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 22 Aug 2008
FDA Approves Nplate(TM) for Long-Term Treatment of Adult Chronic ITP
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Aug 2008
SenoRx and Hologic Agree to Resume Proceedings in Lawsuit
Devices Litigation
 HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Aug 2008
OrthoLogic Announces Chrysalin (TP508) Demonstrates Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Aug 2008
Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke in Patients with Heart Disease, Type 2 Diabetes and Chronic Kidney Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Aug 2008
Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries
Biopharmaceuticals HIV/AIDS Distribution
 HSMN NewsFeed - 31 Jul 2008
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
Diagnostics Oncology FDA
 HSMN NewsFeed - 28 Jul 2008
Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
Devices Surgery
 HSMN NewsFeed - 28 Jul 2008
Head-to-head Study Results Demonstrated No Significant Difference Between NicoDerm(R) CQ(R) and Chantix (Varenicline Tartrate) in Long Term Quit Rates
Biopharmaceuticals
 HSMN NewsFeed - 24 Jul 2008
Santhera Receives First Product Approval: Health Canada Approves Catena(R) for Treatment of Friedreich's Ataxia
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 21 Jul 2008
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Jul 2008
Predictive Biosciences Expands Executive Leadership Team with Two Diagnostic Industry Veteran Appointments
Diagnostics Personnel
 HSMN NewsFeed - 9 Jul 2008
European Commission Announces Marketing Authorisation for 50mg Once Weekly Enbrel(R) for Patients With Moderate-to-Severe Psoriasis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 8 Jul 2008
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
Return to NewsFeed  

 Additional items found! 383

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 383 additional stories matching:
Hologic
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!